Researchers identify the gene believed to be responsible for adverse statin drug side effects in DM2 patients.
Stanford University has launched the DM Biobank to provide high-quality DM biological samples to researchers around the world. By participating in the Biobank, DM community members can play an important role in the development of new therapies that may help patients today and for generations to come.
Interesting Findings Reported in Recent DM Research Studies on Sleep Disturbances
Dr. Katharine Hagerman, Research Associate at Stanford University Neuromuscular Division and Clinics, provides a summary of a recent DM2 sleep survey that has drawn criticism from international DM experts in Italy.
A recently published study from Sweden reported impaired facial recognition in people with DM1 and indicated that there are brain differences that affect how faces are perceived and stored by people with DM1.
SAN FRANCISCO, CA (March 28, 2014): The Myotonic Dystrophy Foundation (MDF) has published the results of its first-ever Fund-a-Fellow Program Assessment measuring the impact of the first five years of its post-doctoral fellowship grant program.